Cargando…

Seroprevalence of anti-SARS-CoV-2 IgG antibodies: relationship with COVID-19 diagnosis, symptoms, smoking, and method of transmission

AIMS: The study of SARS-CoV-2 antibodies in the population is a crucial step towards overcoming the COVID-19 pandemic. Seroepidemiological studies allow an estimation of the number of people who have been exposed to the virus, as well as the number of people who are still susceptible to infection. M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bühler, Kora-Mareen, Echeverry-Alzate, Victor, Calleja-Conde, Javier, Durán-González, Pedro, Segovia-Rodriguez, Lucia, Morales-García, Jose A, Pérez-Wiesner, Mateo, Cables-Chozas, David, de Fonseca, Fernando Rodríguez, Delgado-Iribarren, Alberto, Merino-Amador, Paloma, González-Romo, Fernando, Giné, Elena, López-Moreno, Jose Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Coronavirus (COVID-19) Collection
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9137247/ https://www.ncbi.nlm.nih.gov/pubmed/35720660 http://dx.doi.org/10.1016/j.ijregi.2022.05.007

Ejemplares similares

The Immune System through the Lens of Alcohol Intake and Gut Microbiota
por: Calleja-Conde, Javier, et al.
Publicado: (2021)

Dissecting operant alcohol self‐administration using saccharin‐fading procedure
por: Calleja‐Conde, Javier, et al.
Publicado: (2023)

Classic psychedelics and alcohol use disorders: A systematic review of human and animal studies
por: Calleja‐Conde, Javier, et al.
Publicado: (2022)

SARS-CoV-2 seroprevalence in the city of Hyderabad, India in early 2021
por: Laxmaiah, Avula, et al.
Publicado: (2021)

Seroprevalence of SARS-CoV-2 antibodies in Bangladesh related to novel coronavirus infection
por: Bhuiyan, Taufiqur Rahman, et al.
Publicado: (2022)

Seroprevalence of anti-SARS-CoV-2 antibodies in a population living in Bomassa village, Republic of Congo
por: Lobaloba Ingoba, Line, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a tertiary care hospital in Riyadh, Saudi Arabia
por: Almaghrabi, Reem S., et al.
Publicado: (2021)

Severe acute respiratory syndrome coronavirus 2 antibody seroprevalence in Lebanon: a population-based cross-sectional study
por: Mahdi, Ahmad, et al.
Publicado: (2022)

Seroprevalence of SARS-CoV-2 IgG antibodies in a healthcare setting during the first pandemic wave in Senegal
por: Ahouidi, Ambroise D., et al.
Publicado: (2021)

Changes in SARS-CoV-2 seroprevalence and population immunity in Finland, 2020–2022
por: Solastie, Anna, et al.
Publicado: (2023)

Seroprevalence of anti-SARS-CoV-2 antibodies in Senegal: a national population-based cross-sectional survey, between October and November 2020
por: Talla, Cheikh, et al.
Publicado: (2022)

High anti-SARS-CoV-2 seroprevalence among unvaccinated mother–child pairs from a rural setting in north-eastern Tanzania during the second wave of COVID-19
por: Msemo, Omari Abdul, et al.
Publicado: (2022)

Reinfection rate and disease severity of the BA.5 Omicron SARS-CoV-2 lineage compared to previously circulating variants of concern in the Canary Islands (Spain)
por: Ciuffreda, Laura, et al.
Publicado: (2023)

Impact of SARS-CoV-2 vaccination in healthcare workers in a network of clinics in Latin America
por: Zarabanda, David, et al.
Publicado: (2022)

Gut microbiota and voluntary alcohol consumption
por: Segovia-Rodríguez, L., et al.
Publicado: (2022)

Virological evidence of the impact of non-pharmaceutical interventions against COVID-19 in Ecuador, a resource-limited setting
por: Moreira-Soto, Andres, et al.
Publicado: (2023)

The role of lymphocyte transformation tests (LTT) in suspected severe delayed hypersensitivity reactions following COVID-19 vaccination
por: Weir, Chris, et al.
Publicado: (2023)

Phase 4 clinical trials in the era of the Coronavirus Disease (COVID-19) pandemic and their importance to optimize the COVID-19 vaccination
por: Ralise, Ana Eliza Garcia, et al.
Publicado: (2023)

Hybrid immunity and protection against infection during the Omicron wave in Malta
por: Cauchi, John Paul, et al.
Publicado: (2023)

Clinical characteristics and outcomes of the first two waves of the COVID-19 pandemic in a community hospital: a retrospective cohort study
por: Egoryan, Goar, et al.
Publicado: (2022)

Prevalence of SARS-CoV-2 infection and SARS-CoV-2-specific antibody detection among healthcare workers and hospital staff of a university hospital in Colombia
por: Caballero, Nohemí, et al.
Publicado: (2022)

Outcomes of patients with severe and critical COVID-19 treated with dexamethasone: a prospective cohort study
por: Martinez-Guerra, Bernardo A., et al.
Publicado: (2021)

Plasma miRNA profile at COVID-19 onset predicts severity status and mortality
por: Fernández-Pato, Asier, et al.
Publicado: (2022)

Characteristics and clinical outcomes of COVID-19 in children: a hospital-based surveillance study in Latin America's hardest-hit city
por: Jarovsky, Daniel, et al.
Publicado: (2022)

Predictors of mortality among inpatients with COVID-19 infection in a tertiary referral center in the Philippines
por: Malundo, Anna Flor G., et al.
Publicado: (2022)

Mortality in a swiftly repurposed hospital in northeast Brazil during the first and second COVID-19 waves: A retrospective cohort study
por: Porto, Ana Paula M., et al.
Publicado: (2023)

Clinical characteristics of patients with asymptomatic and symptomatic COVID-19 admitted to a tertiary referral centre in the Philippines
por: Malundo, Anna Flor G., et al.
Publicado: (2022)

Effect of oral antiseptics in reducing SARS-CoV-2 infectivity: evidence from a randomized double-blind clinical trial
por: Sánchez Barrueco, Álvaro, et al.
Publicado: (2022)

Identification of circulating microRNA profiles associated with pulmonary function and radiologic features in survivors of SARS-CoV-2-induced ARDS
por: García-Hidalgo, María C., et al.
Publicado: (2022)

Immunogenicity, safety and reactogenicity of heterologous (third dose) booster vaccination with a full or fractional dose of two different COVID-19 vaccines: A phase 4, single-blind, randomized controlled trial in adults
por: Costa Clemens, Sue Ann, et al.
Publicado: (2023)

Safety and immunogenicity of SCB-2019, an adjuvanted, recombinant SARS-CoV-2 trimeric S-protein subunit COVID-19 vaccine in healthy 12–17 year-old adolescents
por: Lopez, Pio, et al.
Publicado: (2023)

Protection against reinfection with D614- or G614-SARS-CoV-2 isolates in golden Syrian hamster
por: Brustolin, Marco, et al.
Publicado: (2021)

Ten public health strategies to control the Covid-19 pandemic: the Saudi Experience
por: AlFattani, Areej, et al.
Publicado: (2021)

Microbial coinfections and superinfections in critical COVID-19: a Kenyan retrospective cohort analysis
por: Rakiro, Joe, et al.
Publicado: (2021)

Adverse events of Oxford/AstraZeneca's COVID-19 vaccine among health care workers of Ayder Comprehensive Specialized Hospital, Tigray, Ethiopia
por: Tequare, Mengistu Hagazi, et al.
Publicado: (2021)

A review of epidemiology and public health control measures of COVID-19 variants in Hong Kong, December 2020 to June 2021
por: LAM, Ho Yeung, et al.
Publicado: (2021)

Prevalence of COVID-19 in Bangladesh, April to October 2020—a cross-sectional study
por: Nazneen, Arifa, et al.
Publicado: (2021)

COVID-19 vaccine acceptance among healthcare workers in the United Arab Emirates
por: AlKetbi, Latifa Mohammad Baynouna, et al.
Publicado: (2021)

Second round statewide sentinel-based population survey for estimation of the burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population of Karnataka, India, during January-February 2021
por: Padma, M Rajagopal, et al.
Publicado: (2021)

Impact of social activity restriction and routine patient screening as a preventive measurement for tertiary referral hospital staff in a country with high COVID-19 incidence
por: Adrizain, Riyadi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2m34oi8r9cln1ppifp5lo35th6